
Cancer Vaccines Global Market Report 2025
Description
Cancer Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cancer vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for cancer vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer vaccines market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Preventive Cancer Vaccines; Therapeutic Cancer Vaccines
2) By Technology: Dendritic Cells (DC) Cancer Vaccines; Recombinant Cancer Vaccines; Antigen/Adjuvant Cancer Vaccines; Whole Cell Cancer Vaccines; Viral Vector & DNA Cancer Vaccines
3) By Cancer Type: Prostate; Cervical; Colorectal; Throat; Other Cancer Types
4) By End-User: Cancer Treatment Centers; Research Institutes
Subsegments:
1) By Preventive Cancer Vaccines: HPV Vaccines; Hepatitis B Vaccines
2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge); Talimogene Laherparepvec (T-VEC); Other Therapeutic Vaccines
Companies Mentioned: GlaxoSmithKline plc; Merck & Co. Inc.; Aduro Biotech Inc.; AstraZeneca PLC; Dendreon Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on cancer vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cancer vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer vaccines market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Preventive Cancer Vaccines; Therapeutic Cancer Vaccines
2) By Technology: Dendritic Cells (DC) Cancer Vaccines; Recombinant Cancer Vaccines; Antigen/Adjuvant Cancer Vaccines; Whole Cell Cancer Vaccines; Viral Vector & DNA Cancer Vaccines
3) By Cancer Type: Prostate; Cervical; Colorectal; Throat; Other Cancer Types
4) By End-User: Cancer Treatment Centers; Research Institutes
Subsegments:
1) By Preventive Cancer Vaccines: HPV Vaccines; Hepatitis B Vaccines
2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge); Talimogene Laherparepvec (T-VEC); Other Therapeutic Vaccines
Companies Mentioned: GlaxoSmithKline plc; Merck & Co. Inc.; Aduro Biotech Inc.; AstraZeneca PLC; Dendreon Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Cancer Vaccines Market Characteristics
- 3. Cancer Vaccines Market Trends And Strategies
- 4. Cancer Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 5. Global Cancer Vaccines Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cancer Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cancer Vaccines Market Growth Rate Analysis
- 5.4. Global Cancer Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cancer Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cancer Vaccines Total Addressable Market (TAM)
- 6. Cancer Vaccines Market Segmentation
- 6.1. Global Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccines
- 6.2. Global Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dendritic Cells (DC) Cancer Vaccines
- Recombinant Cancer Vaccines
- Antigen/Adjuvant Cancer Vaccines
- Whole Cell Cancer Vaccines
- Viral Vector & DNA Cancer Vaccines
- 6.3. Global Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prostate
- Cervical
- Colorectal
- Throat
- Other Cancer Types
- 6.4. Global Cancer Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cancer Treatment Centers
- Research Institutes
- 6.5. Global Cancer Vaccines Market, Sub-Segmentation Of Preventive Cancer Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- HPV Vaccines
- Hepatitis B Vaccines
- 6.6. Global Cancer Vaccines Market, Sub-Segmentation Of Therapeutic Cancer Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sipuleucel-T (Provenge)
- Talimogene Laherparepvec (T-VEC)
- Other Therapeutic Vaccines
- 7. Cancer Vaccines Market Regional And Country Analysis
- 7.1. Global Cancer Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cancer Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Cancer Vaccines Market
- 8.1. Asia-Pacific Cancer Vaccines Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Cancer Vaccines Market
- 9.1. China Cancer Vaccines Market Overview
- 9.2. China Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Cancer Vaccines Market
- 10.1. India Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Cancer Vaccines Market
- 11.1. Japan Cancer Vaccines Market Overview
- 11.2. Japan Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Cancer Vaccines Market
- 12.1. Australia Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Cancer Vaccines Market
- 13.1. Indonesia Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Cancer Vaccines Market
- 14.1. South Korea Cancer Vaccines Market Overview
- 14.2. South Korea Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Cancer Vaccines Market
- 15.1. Western Europe Cancer Vaccines Market Overview
- 15.2. Western Europe Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Cancer Vaccines Market
- 16.1. UK Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Cancer Vaccines Market
- 17.1. Germany Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Cancer Vaccines Market
- 18.1. France Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Cancer Vaccines Market
- 19.1. Italy Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Cancer Vaccines Market
- 20.1. Spain Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Cancer Vaccines Market
- 21.1. Eastern Europe Cancer Vaccines Market Overview
- 21.2. Eastern Europe Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Cancer Vaccines Market
- 22.1. Russia Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Cancer Vaccines Market
- 23.1. North America Cancer Vaccines Market Overview
- 23.2. North America Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Cancer Vaccines Market
- 24.1. USA Cancer Vaccines Market Overview
- 24.2. USA Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Cancer Vaccines Market
- 25.1. Canada Cancer Vaccines Market Overview
- 25.2. Canada Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Cancer Vaccines Market
- 26.1. South America Cancer Vaccines Market Overview
- 26.2. South America Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Cancer Vaccines Market
- 27.1. Brazil Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Cancer Vaccines Market
- 28.1. Middle East Cancer Vaccines Market Overview
- 28.2. Middle East Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Cancer Vaccines Market
- 29.1. Africa Cancer Vaccines Market Overview
- 29.2. Africa Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Cancer Vaccines Market Competitive Landscape And Company Profiles
- 30.1. Cancer Vaccines Market Competitive Landscape
- 30.2. Cancer Vaccines Market Company Profiles
- 30.2.1. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Aduro Biotech Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Dendreon Corporation Overview, Products and Services, Strategy and Financial Analysis
- 31. Cancer Vaccines Market Other Major And Innovative Companies
- 31.1. Astellas Pharma Inc.
- 31.2. Sanofi SA
- 31.3. Sanpower Group
- 31.4. CSL Limited
- 31.5. Pfizer Inc.
- 31.6. Serum Institute of India Pvt. Ltd.
- 31.7. Advantagene Inc.
- 31.8. Advaxis Inc.
- 31.9. Agenus Inc.
- 31.10. Altor BioScience Corporation
- 31.11. Argos Therapeutics Inc.
- 31.12. Oncothyreon Inc.
- 31.13. Oncovir Inc.
- 31.14. Oxford BioMedica plc
- 31.15. Prima BioMed Ltd.
- 32. Global Cancer Vaccines Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Cancer Vaccines Market
- 34. Recent Developments In The Cancer Vaccines Market
- 35. Cancer Vaccines Market High Potential Countries, Segments and Strategies
- 35.1 Cancer Vaccines Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cancer Vaccines Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cancer Vaccines Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.